Dihydrodesoxymorphine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Dihydrodesoxymorphine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
(One intermediate revision by the same user not shown)
Line 29: Line 29:
{{CMG}}
{{CMG}}
__NOTOC__
__NOTOC__
{{Editor Help}}
 


==Overview==
==Overview==
Line 36: Line 36:


== References ==
== References ==
<references />
{{reflist|2}}


{{opioids}}
{{opioids}}

Latest revision as of 16:47, 4 September 2012

Dihydrodesoxymorphine
Clinical data
SynonymsDesomorphine, Dihydrodesoxymorphine, Permonid
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H21NO2
Molar mass271.354 g/mol
3D model (JSmol)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Desomorphine (Dihydrodesoxymorphine, Permonid) is an opiate analogue invented in 1933 in the United States, that is a derivative of morphine, where the 6-hydroxy group has been removed and the 7,8 double bond has been saturated. It has sedative and analgesic effects, and is around 10 times more potent than morphine.[1][2][3] It was used in Switzerland under the brand name Permonid, and was described as having a fast onset and a short duration of action, with relatively little nausea or respiratory depression compared to equivalent doses of morphine. This drug has attracted recent attention in Russia due to an upsurge in clandestine production, presumably due to its relatively simple synthesis from codeine.[4] It is prepared from α-chlorocodide, which is itself obtained by reacting thionyl chloride with codeine. By catalytic reduction, α-chlorocodide gives dihydrodesoxycodeine, which yields desomorphine on demethylation.[5][6]

References

  1. Bognar R, Makleit S. New method for the preparation of dihydro-6-desoxymorphine. (German). Arzneimittelforschung. 1958 Jun;8(6):323-5. PMID 13546093
  2. Janssen PA. A review of the chemical features associated with strong morphine-like activity. British Journal of Anaesthesia. 1962 Apr;34(4):260-268. PMID 14451235
  3. Sargent LJ, May EL. Agonists--antagonists derived from desomorphine and metopon. Journal of Medicinal Chemistry. 1970 Nov;13(6):1061-3. PMID 4098039
  4. Drug police RB is alarmed with growth of Desomorphine usage
  5. Mosettig E, Cohen FL, Small LF. Desoxycodeine Studies. III. The Constitution of the So-Called Alpha-Dehydrodesoxycodeine: Bis-Di-hydrodesoxycodeine. Journal of the American Chemical Society 1932; 54:793-801.
  6. Eddy NB, Howes HA. Studies of Morphine, Codeine and their Derivatives X. Desoxymorphine-C, Desoxycodeine-C and their Hydrogenated Derivatives. Journal of Pharmacology And Experimental Therapeutics. 1935; 55(3):257-267.

Template:Opioids



Template:WikiDoc Sources